RELEUKO (Filgrastim)

**Product type:** Human Prescription Drug

**Active ingredient:** FILGRASTIM

**Strength:** 480 ug/1.6mL

**Dosage form:** Injection, Solution

**Route:** Intravenous; Subcutaneous

**Labeler:** Amneal Pharmaceuticals LLC

**Marketing category:** BLA (BLA761082)

**Pharmacologic class:** Granulocyte Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]